Prevention of head and neck cancer

被引：8

作者：

Day T.A. ^{[1
]}

Chi A. ^{[1
]}

Neville B. ^{[1
]}

Hebert J.R. ^{[1
]}

机构：

[1] Head and Neck Tumor Program, Hollings Cancer Center, Medical University of South Carolina, Charleston, SC 29425

来源：

Current Oncology Reports | 2005年 / 7卷 / 2期

关键词：

Neck Cancer; Oral Cancer; Isotretinoin; Neck Squamous Cell Carcinoma; Amifostine;

D O I：

10.1007/s11912-005-0041-x

中图分类号：

学科分类号：

摘要：

In the vast majority of cases, head and neck cancer is a preventable disease. The relationship between tobacco and alcohol and these cancers is well established. Despite efforts aimed at reduction of risk factor exposure and early detection methods, head and neck cancer remains one of the more common cancers worldwide. Recent advances in molecular techniques have provided a framework for future targets for early diagnosis and treatment of these malignancies. This review provides a summary of recent developments in primary and secondary prevention of head and neck cancer and innovative strategies aimed at a reduction in incidence and mortality from this disease. The future prevention of head and neck cancer will likely require solutions to the widespread use of tobacco products and innovative diagnostic techniques leading to improvements in overall survival. Copyright © 2005 by Current Science Inc.

引用

页码：145 / 153

页数：8

共 91 条

[1]

Parkin D.M., Pisani P., Ferlay J., Estimates of the worldwide incidence of 25 major cancers in 1990, Int. J. Cancer, 80, pp. 827-841, (1999)

[2]

Mignogna M.D., Fedele S., Russo L.L., The World Cancer Report and the burden of oral cancer, Eur. J. Cancer Prev., 13, pp. 139-142, (2004)

[3]

Cmelak A.J., Murphy B.A., Day T., Combined-modality therapy for locoregionally advanced head and neck cancer, Oncology (Huntingt.), 13, SUPPL. 5, pp. 83-91, (1999)

[4]

Califano J., van der Riet P., Westra W., Et al., Genetic progression model for head and neck cancer: Implications for field cancerization, Cancer Res., 56, pp. 2488-2492, (1996)

[5]

Gleich L.L., Salamone F.N., Molecular genetics of head and neck cancer, Cancer Control, 9, pp. 369-378, (2002)

[6]

Kashiwazaki H., Tonoki H., Tada M., Et al., High frequency of p53 mutations in human oral epithelial dysplasia and primary squamous cell carcinoma detected by yeast functional assay, Oncogene, 15, pp. 2667-2674, (1997)

[7]

Meredith S.D., Levine P.A., Burns J.A., Et al., Chromosome 11q13 amplification in head and neck squamous cell carcinoma: Association with poor prognosis, Arch. Otolaryngol. Head Neck Surg., 121, pp. 790-794, (1995)

[8]

Michalides R.J., van Veelen N.M., Kristel P.M., Et al., Overexpression of cyclin D1 indicates a poor prognosis in squamous cell carcinoma of the head and neck, Arch. Otolaryngol. Head Neck Surg., 123, pp. 497-502, (1997)

[9]

Sudbo J., Lippman S.M., Lee J.J., Et al., The influence of resection and aneuploidy on mortality in oral leukoplakia, N. Engl. J. Med., 350, pp. 1405-1413, (2004)

[10]

Miyaguchi A., Olofsson M.J., Hellquist H.B., Expression of epidermal growth factor receptor in laryngeal dysplasia and carcinoma, Acta Otolaryngol., 110, pp. 309-313, (1990)

← 1 2 3 4 5 6 7 8 9 10 →